[Use of bronchovaxom in the treatment of patients with chronic obstructive bronchitis and bronchial asthma].
Polyvalent vaccine bronchovaxom (BV) was studied for efficacy against chronic obstructive bronchitis and bronchial asthma exacerbation. Good results were reported: reduction of disability duration, number of recurrences, cough intensity, discharged sputum. Laboratory tests discovered that BV brought about IgE decrease, IgA, T3, T4/T8 increase in bronchoalveolar lavage.
Shmelev
E I
EI
Sokolova
L V
LV
Kosmiadi
G A
GA
Abramova
Z P
ZP
Filippov
V P
VP
Evgushchenko
G V
GV
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000284:Administration, Oral; D001249:Asthma / Q000276:immunology / Q000628:therapy*; D001419:Bacteria; D001991:Bronchitis / Q000276:immunology / Q000628:therapy*; D002457:Cell Extracts; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology; D000095983:Bacterial Lysates
D000276:Adjuvants, Immunologic; D002457:Cell Extracts; D007136:Immunoglobulins; D007155:Immunologic Factors; C030259:Broncho-Vaxom; D000095983:Bacterial Lysates